NZ756701A - Intradialytic use of sodium nitrite - Google Patents

Intradialytic use of sodium nitrite

Info

Publication number
NZ756701A
NZ756701A NZ756701A NZ75670118A NZ756701A NZ 756701 A NZ756701 A NZ 756701A NZ 756701 A NZ756701 A NZ 756701A NZ 75670118 A NZ75670118 A NZ 75670118A NZ 756701 A NZ756701 A NZ 756701A
Authority
NZ
New Zealand
Prior art keywords
nitrite
dialysate
use according
sodium nitrite
subject
Prior art date
Application number
NZ756701A
Other languages
English (en)
Inventor
Craig Sherman
Original Assignee
Hope Medical Entpr Inc Dba Hope Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hope Medical Entpr Inc Dba Hope Pharmaceuticals filed Critical Hope Medical Entpr Inc Dba Hope Pharmaceuticals
Publication of NZ756701A publication Critical patent/NZ756701A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ756701A 2017-03-08 2018-03-06 Intradialytic use of sodium nitrite NZ756701A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762468857P 2017-03-08 2017-03-08
PCT/US2018/021053 WO2018165098A1 (en) 2017-03-08 2018-03-06 Intradialytic use of sodium nitrite

Publications (1)

Publication Number Publication Date
NZ756701A true NZ756701A (en) 2022-07-01

Family

ID=63445965

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ756701A NZ756701A (en) 2017-03-08 2018-03-06 Intradialytic use of sodium nitrite

Country Status (15)

Country Link
US (5) US10328099B2 (enExample)
EP (2) EP3592342B1 (enExample)
JP (3) JP7314050B2 (enExample)
KR (4) KR102647803B1 (enExample)
AR (1) AR111166A1 (enExample)
AU (2) AU2018231016B2 (enExample)
BR (1) BR112019018861A2 (enExample)
CA (1) CA3055105A1 (enExample)
ES (1) ES2986444T3 (enExample)
IL (4) IL301302B2 (enExample)
NZ (1) NZ756701A (enExample)
PH (1) PH12019501950A1 (enExample)
TW (3) TWI798203B (enExample)
WO (1) WO2018165098A1 (enExample)
ZA (3) ZA201905679B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL301302B2 (en) 2017-03-08 2024-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium nitrite
ES2992792T3 (en) 2017-03-08 2024-12-18 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Intradialytic use of sodium thiosulfate
KR102875863B1 (ko) * 2019-07-22 2025-10-23 스쿨 주리디칼 퍼슨 키타사토 인스티튜트 투석 장치
US20230149732A1 (en) * 2021-11-17 2023-05-18 Wake Forest University Health Sciences Combined nitrite and light treatment to prevent device thrombosis
US12128166B2 (en) 2022-12-16 2024-10-29 Fresenius Medical Care Holdings, Inc. Systems and methods for using nitric oxide in dialysis

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341151C (en) 1985-09-10 2000-12-05 Elias Klein Osmotic agents form peritoneal dialysis
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
FI98538C (fi) 1993-10-20 1997-07-10 Enso Gutzeit Oy Menetelmä natriumhydroksidin valmistamiseksi valkolipeästä
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
US6436969B1 (en) 1995-09-12 2002-08-20 Kansas University Medical Center Research Institute Inc. Dialysis solutions and methods
JP4882054B2 (ja) 2000-09-13 2012-02-22 独立行政法人科学技術振興機構 腹膜透析液およびその調製法
CA2537222A1 (en) * 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20070154570A1 (en) * 2004-09-29 2007-07-05 Miller Christopher C Use of nitric oxide in the treatment and disinfection of biofilms
US7547637B2 (en) * 2005-06-21 2009-06-16 Intel Corporation Methods for patterning a semiconductor film
US20090304600A1 (en) 2008-06-09 2009-12-10 Anupkumar Shetty Intradialytic administration of sodium thiosulfate
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
DK2451435T4 (da) 2009-07-08 2022-02-28 Hope Medical Entpr Inc D B A Hope Pharmaceuticals Natriumthiosulfat-indeholdende farmaceutiske sammensætninger
WO2013023217A1 (en) * 2011-08-11 2013-02-14 Board Of Regents, The University Of Texas System Method of measuring and monitoring in vivo nitrite levels
AU2013212264B2 (en) 2012-01-23 2017-05-18 Santalis Pharmaceuticals Inc. Sandalwood oil and its uses related to clostridium infections
JP5486069B1 (ja) 2012-11-05 2014-05-07 旭 酒井 透析装置
US20140350097A1 (en) 2013-05-23 2014-11-27 Medinox,Inc. Treatment of hypotension associated with hemodialysis
JP6183832B2 (ja) 2013-06-19 2017-08-23 扶桑薬品工業株式会社 酸化ストレス抑制型透析用剤およびその調製方法
IL301302B2 (en) 2017-03-08 2024-09-01 Hope Medical Entpr Inc Dba Hope Pharmaceuticals Intradialytic use of sodium nitrite

Also Published As

Publication number Publication date
KR20250017763A (ko) 2025-02-04
CA3055105A1 (en) 2018-09-13
KR102760913B1 (ko) 2025-02-03
EP3592342A4 (en) 2020-12-23
JP2020510014A (ja) 2020-04-02
ES2986444T3 (es) 2024-11-11
AU2018231016B2 (en) 2024-03-07
IL284684B2 (en) 2023-08-01
IL301302A (en) 2023-05-01
US20190255098A1 (en) 2019-08-22
EP4406595A3 (en) 2024-10-30
IL312092B1 (en) 2025-04-01
KR20190130588A (ko) 2019-11-22
EP3592342A1 (en) 2020-01-15
TW201836594A (zh) 2018-10-16
US11564938B2 (en) 2023-01-31
IL301302B1 (en) 2024-05-01
JP2024174935A (ja) 2024-12-17
US20210077524A1 (en) 2021-03-18
PH12019501950A1 (en) 2020-06-15
JP2023134621A (ja) 2023-09-27
KR102647803B1 (ko) 2024-03-15
TWI835595B (zh) 2024-03-11
IL312092A (en) 2024-06-01
ZA201905679B (en) 2023-02-22
EP3592342B1 (en) 2024-06-19
JP7765687B2 (ja) 2025-11-07
ZA202208504B (en) 2024-01-31
TW202325265A (zh) 2023-07-01
AU2018231016A1 (en) 2019-09-19
AU2024203535A1 (en) 2024-06-20
JP7314050B2 (ja) 2023-07-25
TW202421096A (zh) 2024-06-01
ZA202307367B (en) 2024-11-27
IL268882B (en) 2021-07-29
KR102706379B1 (ko) 2024-09-19
US20180256637A1 (en) 2018-09-13
BR112019018861A2 (pt) 2023-10-10
IL312092B2 (en) 2025-08-01
IL268882A (en) 2019-10-31
KR20240038812A (ko) 2024-03-25
US10328099B2 (en) 2019-06-25
TWI798203B (zh) 2023-04-11
IL284684A (en) 2021-08-31
JP7551858B2 (ja) 2024-09-17
WO2018165098A1 (en) 2018-09-13
TWI888012B (zh) 2025-06-21
IL284684B1 (en) 2023-04-01
KR20240137711A (ko) 2024-09-20
AR111166A1 (es) 2019-06-12
US10898512B2 (en) 2021-01-26
US20240285677A1 (en) 2024-08-29
EP4406595A2 (en) 2024-07-31
US12011456B2 (en) 2024-06-18
US20230256005A1 (en) 2023-08-17
IL301302B2 (en) 2024-09-01

Similar Documents

Publication Publication Date Title
US12011456B2 (en) Intradialytic use of sodium nitrite
US12370212B2 (en) Intradialytic use of sodium thiosulfate
NZ789172A (en) Intradialytic use of sodium nitrite
NZ788158A (en) Intradialytic use of sodium thiosulfate

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 MAR 2024 BY COMPUTER PACKAGES INC

Effective date: 20230417

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 MAR 2025 BY COMPUTER PACKAGES INC

Effective date: 20240217

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 06 MAR 2026 BY COMPUTER PACKAGES INC

Effective date: 20250217